Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify SCOTT D. KAHN, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| EXAGEN INC. | 2024-04-26 | Previously, Dr. Kahn served 11 years as the first Chief Information Officer for Illumina, Inc. (NASDAQ: ILMN), and he was also an executive leader in Illumina's Enterprise Informatics Unit. He organized the Genome Informatics Alliance for five years to drive interdisciplinary thought leadership focused on the future of Next Generation Sequencing and its role in precision medicine, healthcare, and other applied markets. Dr. Kahn has a Ph.D. in Theoretical Organic Chemistry from the University of California, Irvine. | Has a Ph.D. in Theoretical Organic Chemistry and extensive experience as Chief Information Officer and in informatics and data science strategy, indicating strong technical and software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-26 | Previously, Dr. Kahn served 11 years as the first Chief Information Officer for Illumina, Inc. (NASDAQ: ILMN), and he was also an executive leader in Illumina's Enterprise Informatics Unit. He organized the Genome Informatics Alliance for five years to drive interdisciplinary thought leadership focused on the future of Next Generation Sequencing and its role in precision medicine, healthcare, and other applied markets. Dr. Kahn has a Ph.D. in Theoretical Organic Chemistry from the University of California, Irvine. |
Data sourced from SEC filings. Last updated: 2026-02-03